Clinical Trials Logo

Supraspinatus Tear clinical trials

View clinical trials related to Supraspinatus Tear.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05335785 Enrolling by invitation - Supraspinatus Tear Clinical Trials

Efficacy of High Intensity Lazer Therapy in Partial Supraspinatus Tear

Start date: December 2, 2020
Phase: N/A
Study type: Interventional

Rotatorcuff lesions constitute 10% of the causes of shoulder pain. Supraspinatus tear is one of the common rotatorcuff lesions. It affects the quality of life negatively and causes loss of range of motion and muscle strength. It can be seen due to traumatic or degenerative causes. Its incidence increases with advanced age. While the incidence was reported as 4% in the population aged 40-60 years, this rate was reported to be 17-50% in the group over the age of 60 and 80% in the group over the age of 80. Radiologically, classification is made as partial or full-thickness tears. Rotatorcuff tears can be treated conservatively or surgically. Although the risk of post-surgical rupture is reduced with new methods, the lack of desired tendon healing has led to the search for alternative applications such as biological augmentation and high-intensity laser. The aim of this study is to reveal the effectiveness of high-intensity laser therapy in patients with partial supraspinatus tear.

NCT ID: NCT01414764 Enrolling by invitation - Supraspinatus Tear Clinical Trials

Does Autologous Conditioned Plasma Enhance Rotator Cuff Tendon Healing After Surgery?

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The aim of this study is to establish if the application of autologous conditioned plasma (ACP), also described as platelet rich plasma (PRP), to the site of supraspinatus tendon repair beginning within two weeks of surgery, can improve patient outcomes over the course of 12 months. These outcomes will be measured by post-surgical pain and function scores, shoulder strength and range of motion (ROM), and radiological parameters of tendon healing. Outcome measures will be compared to a control group of patients receiving placebo injections following surgery (saline plus local anaesthetic). This study is significant for being the first double blind randomised control trial, using two PRP injections to examine the efficacy of a PRP preparation following surgical repair of supraspinatus tendon. The objective is to prolong and enhance the tendon healing response initiated by surgery. The research hypothesis is that enhanced tendon healing following the PRP injections will lead to more rapid rehabilitation and lower rates of re-rupture of the repaired tendon compared to the control group.